The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis

Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis

(2014) B. Vigone et al.   RHEUMATOLOGY

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

CXCL13 and B-cell activating factor as putative biomarkers in systemic sclerosis

(2013) N. Wutte et al.   BRITISH JOURNAL OF DERMATOLOGY

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

(2013) Lenny van Bon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression

(2012) Zana Brkic et al.   ANNALS OF THE RHEUMATIC DISEASES

Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis

(2012) Xiaochun Liu et al.   ARTHRITIS AND RHEUMATISM

The interferon signature in autoimmune diseases

(2012) Lars Rönnblom et al.   CURRENT OPINION IN RHEUMATOLOGY

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

(2011) B. W. Higgs et al.   ANNALS OF THE RHEUMATIC DISEASES

B Cell and BAFF Dependence of IFN- -Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice

(2011) N. Jacob et al.   JOURNAL OF IMMUNOLOGY

Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus

(2011) G. S. Garcia-Romo et al.   Science Translational Medicine

Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts

(2011) Sandeep K Agarwal et al.   ARTHRITIS RESEARCH & THERAPY

Type I interferon system activation and association with disease manifestations in systemic sclerosis

(2010) M.-L. Eloranta et al.   ANNALS OF THE RHEUMATIC DISEASES

A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis

(2010) G. Farina et al.   ARTHRITIS AND RHEUMATISM

Polymorphisms inTBX21andSTAT4increase the risk of systemic sclerosis: Evidence of possible gene–gene interaction and alterations in Th1/Th2 cytokines

(2009) Pravitt Gourh et al.   ARTHRITIS AND RHEUMATISM

STAT4is a genetic risk factor for systemic sclerosis having additive effects withIRF5on disease susceptibility and related pulmonary fibrosis

(2009) P. Dieudé et al.   ARTHRITIS AND RHEUMATISM

Association of a functional polymorphism in theIRF5region with systemic sclerosis in a Japanese population

(2009) Ikue Ito et al.   ARTHRITIS AND RHEUMATISM

The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype

(2009) B. Rueda et al.   HUMAN MOLECULAR GENETICS

Scleroderma

(2009) Armando Gabrielli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Induction of interferon‐α by scleroderma sera containing autoantibodies to topoisomerase I: Association of higher interferon‐α activity with lung fibrosis

(2008) Daniel Kim et al.   ARTHRITIS AND RHEUMATISM

Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma

(2008) Hangjun Duan et al.   ARTHRITIS AND RHEUMATISM

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis

(2008) Martial Koenig et al.   ARTHRITIS AND RHEUMATISM